Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rajeev Zachariah Kompithra"'
Autor:
Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, Sanjay Lalwani, Monjori Mitra, Amita Sapru, Shruti Saha, P.V. Varughese, Rajeev Zachariah Kompithra, Sanjay Gandhi
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4646-4653 (2021)
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6–10
Externí odkaz:
https://doaj.org/article/5d35f76d2617450b9901c97811e1abfb
Autor:
Mark Rohit Francis, J. Pekka Nuorti, Kirsi Lumme-Sandt, Rajeev Zachariah Kompithra, Vinohar Balraj, Gagandeep Kang, Venkata Raghava Mohan
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background In 2015, the Vellore district in southern India was selected for intensified routine immunization, targeting children from communities experiencing disadvantage such as migrant, tribal, and other hard-to-reach groups. This mixed-m
Externí odkaz:
https://doaj.org/article/744efd2c6c6647e48e95a0c4e3a4fbc2
Autor:
Sharad Agarkhedkar, Jugesh Chhatwal, Rajeev Zachariah Kompithra, Sanjay K. Lalwani, Arun Narayan, Vinay Muninarayanaswam, Nithya Gogtay, Kristin Dotter, Viviane Gresset-Bourgeois
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 973-977 (2019)
A quadrivalent split-virion inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent, Sanofi Pasteur) has been available in the US since 2013 for individuals aged ≥ 6 months. Here, we describe the results of an open-label, multicenter trial (WHO
Externí odkaz:
https://doaj.org/article/56996f89851f45738c47ed28960a797c
Autor:
Rajeev Zachariah Kompithra, Dan Bi, Amita Sapru, Adrian Caplanusi, Shruti Saha, Leentje Moerman, Brigitte Cheuvart, Sanjay Gandhi, Mallesh Kariyappa, Sanjay Lalwani, Catherine Cohet, Monjori Mitra, P.V. Varughese
Publikováno v:
Human Vaccines & Immunotherapeutics. 17:4646-4653
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6-10 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86bdf4be4266e2b38f3c6d5badc7ee0
https://doi.org/10.1080/21645515.2021.1960136
https://doi.org/10.1080/21645515.2021.1960136
Autor:
Mark Francis, Gagandeep Kang, Venkata Raghava Mohan, Rajeev Zachariah Kompithra, Vinohar Balraj, Heidi J. Larson, J. Pekka Nuorti
Publikováno v:
Vaccine. 37:3078-3087
BACKGROUND: Vellore district in southern India was selected for intensified immunization efforts through India's Mission Indradhanush campaign based on 74% coverage in the National Family Health Survey in 2015. As rural households rely almost entirel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec7c4b5517bf4ed36f1f5d4cbb7ff35
https://doi.org/10.1016/j.vaccine.2019.04.058
https://doi.org/10.1016/j.vaccine.2019.04.058
Autor:
Viviane Gresset-Bourgeois, Nithya J Gogtay, Sanjay Lalwani, Jugesh Chhatwal, Sharad Agarkhedkar, Kristin Dotter, Arun Narayan, Rajeev Zachariah Kompithra, Vinay Muninarayanaswam
Publikováno v:
Human Vaccines & Immunotherapeutics
A quadrivalent split-virion inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent, Sanofi Pasteur) has been available in the US since 2013 for individuals aged ≥ 6 months. Here, we describe the results of an open-label, multicenter trial (WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3163f6aad6d2d9f42ddb4d2931e70f6
https://doi.org/10.1080/21645515.2019.1565259
https://doi.org/10.1080/21645515.2019.1565259
Autor:
Bakul B Javadekar, Olga Perminova, Yaël Thollot, Alexander Goldstein, Apurba Ghosh, Shally Awasthi, Susanna Kharit, Vera Rodnikova, Valérie Bosch-Castells, Romanenko Vv, Himanshu Dubey, Rajeev Zachariah Kompithra
Publikováno v:
Indian pediatrics. 55(12)
Evaluation of tolerability, safety and immunogenicity of a two-dose series of a quadrivalent meningococcal polysaccharide diptheria toxoid conjugate (ACYW-D) vaccine in Indian and Russian infants/toddlers. Open-label, single-arm, phase III multi-nati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4dc185e8477bbbea854ea1e29fee9a
https://pubmed.ncbi.nlm.nih.gov/30745476
https://pubmed.ncbi.nlm.nih.gov/30745476
Autor:
Kanika Goyal, Jacob Puliyel, Rajeev Zachariah Kompithra, S. Nivedhana, Shobana Rajendran, Shridhar Gopalakrishnan, Kirandeep Sodhi, Pareshkumar Thakkar, Nirali Sanghvi
Publikováno v:
Indian Pediatrics. 53:351-354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21a81b068850e58880833322ce884db5
https://doi.org/10.1007/s13312-016-0853-9
https://doi.org/10.1007/s13312-016-0853-9
Autor:
Valsan Philip Verghese, Leni G. Mathew, T. Jacob John, Magdalenal R, Rajeev Zachariah Kompithra
Publikováno v:
Journal of Immunization. 1:1-8
The Expanded Program on Immunization (EPI) in India delivers vaccines under its policy, through government hospitals, health centers and outreach clinics. However, the national average full immunization coverage is stagnating at about 70%. The days a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5fbca759844f30eaa764cc9a187c509
https://doi.org/10.14302/issn.2577-137x.ji-15-834
https://doi.org/10.14302/issn.2577-137x.ji-15-834
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of prophylactic paracetamol to prevent fever in children receiving vaccination as part of a childhood immunization schedule.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f45ab5f9c412a2560c2d9b30e3de9d
https://doi.org/10.1002/14651858.cd012655
https://doi.org/10.1002/14651858.cd012655